Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
2(20%)
Results Posted
38%(3 trials)

Phase Distribution

Ph phase_2
4
40%
Ph phase_1
3
30%
Ph phase_3
1
10%
Ph not_applicable
1
10%

Phase Distribution

3

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 2Efficacy & side effects
4(44.4%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(8)

Detailed Status

Completed8
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (33.3%)
Phase 24 (44.4%)
Phase 31 (11.1%)
N/A1 (11.1%)

Trials by Status

completed880%
recruiting220%

Recent Activity

2 active trials
Showing 5 of 10
recruiting

Use of Cysteamine in the Treatment of Cystinosis

NCT00359684
completedphase_2

Effectiveness of a Bilayering Serum and Cream Containing GABA, DMAE, Cysteamine, and Bakuchiol for Skin Whitening and Anti-Aging

NCT07477288
recruitingphase_3

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

NCT02735707
completedphase_2

A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations

NCT03000348
completednot_applicable

Efficacy of Topical Cysteamine in Nephropathic Cyctinosis

NCT02766855
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT00359684

Use of Cysteamine in the Treatment of Cystinosis

Recruiting
NCT07477288Phase 2

Effectiveness of a Bilayering Serum and Cream Containing GABA, DMAE, Cysteamine, and Bakuchiol for Skin Whitening and Anti-Aging

Completed
NCT02735707Phase 3

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Recruiting
NCT03000348Phase 2

A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations

Completed
NCT02766855Not Applicable

Efficacy of Topical Cysteamine in Nephropathic Cyctinosis

Completed
NCT02212431Phase 1

First Study of Oral Cysteamine in Cystic Fibrosis

Completed
NCT00001213Phase 2

Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis

Completed
NCT00799578Phase 1

A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)

Completed
NCT00001736Phase 1

New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis

Completed
NCT00002110Phase 2

A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10